Takeda Pharmaceutical Company Limited Stock NYSE
Stocks
TAK
US8740602052
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.77 USD | -0.88% |
|
+1.09% | +1.15% |
| Market Cap | 8,038B 50.12B 43.26B 39.85B 37.39B 70.12B 4,747B 70.91B 467B 184B 2,321B 188B 184B | P/E Ratio 2026 |
46.4x | P/E Ratio 2027 * | 39.6x |
|---|---|---|---|---|---|
| Enterprise Value | 11,978B 74.68B 64.47B 59.37B 55.71B 104B 7,074B 106B 697B 273B 3,459B 280B 274B | EV / Sales 2026 |
1.14x | EV / Sales 2027 * | 2.58x |
| Free-Float |
99.25% | Yield 2026 |
3.53% | Yield 2027 * | 4.02% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -0.88% | ||
| 1 week | +1.09% | ||
| Current month | -1.19% | ||
| 1 month | -5.17% | ||
| 3 months | -11.25% | ||
| 6 months | +10.05% | ||
| Current year | +1.15% |
| 1 week | 15.59 |  | 16.02 |
| 1 month | 14.84 | | 16.74 |
| Current year | 14.84 | | 18.9 |
| 1 year | 12.99 | | 18.9 |
| 3 years | 12.58 | | 18.9 |
| 5 years | 12.28 | | 18.9 |
| 10 years | 12.28 | | 31.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 59 | 2015-03-31 |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 2024-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 2022-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Christophe Weber
BRD | Director/Board Member | 59 | 2014-05-31 |
Andrew Plump
BRD | Director/Board Member | 60 | 2015-05-31 |
| Director/Board Member | 74 | 2016-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.88% | +1.09% | - | - | 50.12B | |
| -0.32% | -0.18% | +37.83% | +152.24% | 1,010B | |
| -2.16% | +1.24% | +50.01% | +45.87% | 580B | |
| -2.70% | -2.48% | +15.97% | +62.66% | 402B | |
| +0.77% | 0.00% | +21.28% | +19.14% | 330B | |
| -1.52% | +1.90% | +23.73% | +34.08% | 281B | |
| -1.95% | -4.75% | +20.15% | +14.68% | 280B | |
| -0.57% | +0.62% | -44.67% | -47.65% | 197B | |
| -1.31% | +0.27% | +18.74% | +57.70% | 192B | |
| -0.38% | -3.76% | +13.02% | +59.46% | 156B | |
| Average | -0.06% | +0.84% | +17.34% | +44.24% | 380.97B | |
| Weighted average by Cap. | +0.02% | +1.04% | +26.19% | +69.00% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 4,531B 28.25B 24.39B 22.46B 21.08B 39.53B 2,676B 39.98B 263B 103B 1,309B 106B 104B | 4,623B 28.82B 24.88B 22.92B 21.5B 40.33B 2,730B 40.78B 269B 106B 1,335B 108B 106B |
| Net income | 174B 1.09B 939M 865M 811M 1.52B 103B 1.54B 10.15B 3.98B 50.39B 4.08B 4B | 193B 1.2B 1.04B 955M 896M 1.68B 114B 1.7B 11.2B 4.4B 55.62B 4.51B 4.41B |
| Net Debt | 3,940B 24.56B 21.2B 19.53B 18.32B 34.37B 2,327B 34.76B 229B 89.94B 1,138B 92.21B 90.25B | 3,881B 24.2B 20.89B 19.24B 18.05B 33.85B 2,292B 34.24B 226B 88.6B 1,121B 90.83B 88.9B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-15 | 15.77 $ | -0.88% | 2,090,910 |
| 26-06-12 | 15.91 $ | +0.25% | 3,971,656 |
| 26-06-11 | 15.87 $ | +1.21% | 2,274,283 |
| 26-06-10 | 15.68 $ | -0.25% | 2,416,833 |
| 26-06-09 | 15.72 $ | -0.13% | 4,585,570 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
- TAK Stock
Select your edition
All financial news and data tailored to specific country editions
